+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Marine Derived Drugs Market by Source (Macroalgae, Marine Bacteria, Marine Fungi), Drug Type (Anti-Inflammatory Agents, Antibiotics, Anticancer Agents), Form, Applications, End-User - Global Forecast 2025-2030- Product Image
Marine Derived Drugs Market by Source (Macroalgae, Marine Bacteria, Marine Fungi), Drug Type (Anti-Inflammatory Agents, Antibiotics, Anticancer Agents), Form, Applications, End-User - Global Forecast 2025-2030- Product Image
Sale

Marine Derived Drugs Market by Source (Macroalgae, Marine Bacteria, Marine Fungi), Drug Type (Anti-Inflammatory Agents, Antibiotics, Anticancer Agents), Form, Applications, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904827
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders seeking innovative growth opportunities in the pharmaceutical sector are turning their attention to the marine derived drugs market. This evolving field harnesses the distinctive bioactive potential of marine resources to meet complex therapeutic needs and unlock alternative drug development pathways.

Market Snapshot: Marine Derived Drugs Market

The marine derived drugs market grew from USD 4.39 billion in 2024 to USD 4.77 billion in 2025. It is expected to continue growing at a CAGR of 9.29%, reaching USD 7.48 billion by 2030. Marine ecosystems serve as rich reservoirs of novel compounds, supporting product pipelines from initial discovery to late-stage clinical candidates. This dynamic landscape is shaped by rapid advances in biotechnological platforms, improved analytical tools, and the expansion of collaborative research networks worldwide.

Scope & Segmentation

  • Source: Macroalgae (brown, green, red seaweed), marine bacteria (Actinobacteria, Proteobacteria), marine fungi, marine sponges (Halichondria okadai, Theonella swinhoei), microalgae (Chlorella, Dunaliella, Spirulina).
  • Drug Type: Anti-inflammatory agents, antibiotics (broad-spectrum, narrow-spectrum), anticancer agents (apoptotic, cytotoxic), antimicrobial, antiviral agents (influenza treatment, retroviral treatment), cardiovascular drugs (anticoagulants, blood pressure regulators).
  • Form: Liquid, semi-solid, solid.
  • Applications: Cosmeceuticals (hair care, skin care), nutraceuticals (dietary supplements, functional foods), pharmaceuticals (cardiovascular, oncology).
  • End-User: Hospitals, clinics, research and academic institutions.
  • Region: Americas (with key focus on United States regions), Europe, Middle East, Africa, Asia-Pacific (including major markets and emerging economies).
  • Key Technologies: Advanced analytical chemistry, high-resolution mass spectrometry, synthetic biology, integrative omics, AI/ML-driven screening, and next-gen cold-chain logistics.
  • Industry Players Profiled: Leading global and niche organizations, including Pharmamar S.A., Marinomed Biotech AG, BASF Pharma, Pfizer Inc., Takeda Pharmaceutical Company Limited, and BioMarin Pharmaceutical Inc.

Key Takeaways for Decision-Makers

  • Marine bioprospecting is positioned as a strategic pillar reshaping traditional drug discovery models, supported by advances in sampling and sustainability practices.
  • Integration of omics technologies and machine learning is reducing compound development timelines, enhancing both early lead identification and safety assessment.
  • Synthetic biology platforms are enabling scalable, sustainable production of rare marine-derived compounds, addressing historic challenges related to supply and yield.
  • Growing collaborations among biotech firms, academia, and established pharmaceutical companies are further solidifying innovation ecosystems and accelerating market entry.
  • Distinctive regional strengths, such as robust clinical research in the Americas and evolving regulatory harmonization in EMEA, are shaping investment priorities and partnership models worldwide.
  • Segment diversity—from cosmeceuticals to oncology—creates multiple entry points and flexibility for organizations targeting marine pharmaceutical innovation.

Tariff Impact: Navigating 2025 Policy Shifts in Marine Derived Drugs

The introduction of United States tariffs in 2025 has prompted a recalibration of procurement and supply chain strategies across the marine therapeutics sector. Companies are adapting by forming new domestic partnerships, advancing onshore fermentation, and upgrading logistics infrastructure to safeguard compound integrity and mitigate regulatory delays. These shifts are fostering resilient, regionally-integrated supply ecosystems and encouraging innovation in sourcing and distribution.

Methodology & Data Sources

This research combines primary interviews with senior marine biology and pharmaceutical experts, as well as in-depth secondary analysis of scientific journals, industry white papers, and regulatory filings. Triangulation of data from multiple sources reinforces the reliability and relevance of findings for decision-makers who demand rigour in market intelligence.

Why This Report Matters

  • Empowers organizations to recognize emerging technological and partnership trends that are reshaping the competitive landscape in marine derived drugs.
  • Provides segmentation insights and actionable recommendations for supply chain resilience and regulatory adaptation, enabling informed strategic planning.
  • Offers a clear framework to benchmark organizational positioning against leading industry players and evolving global best practices.

Conclusion

The marine derived drugs market offers a pathway to diversified innovation, operational resilience, and cross-sector collaboration. Well-informed decision-making positions stakeholders to optimize opportunities in this complex, fast-evolving industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing investment in sustainable aquaculture methods to source bioactive marine compounds
5.2. Advancements in synthetic biology enabling large scale production of marine-derived anticancer agents
5.3. Growing collaborations between pharmaceutical companies and marine biology institutes for novel drug discovery
5.4. Regulatory framework evolution promoting expedited approval pathways for marine-based therapeutics
5.5. Integration of artificial intelligence in screening marine microbiome libraries for new drug candidates
5.6. Rising interest in marine-derived peptides as treatment for neurodegenerative disorders such as Alzheimer’s disease
5.7. Development of eco-friendly extraction technologies minimizing environmental impact of marine resource harvesting
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Marine Derived Drugs Market, by Source
8.1. Introduction
8.2. Macroalgae
8.2.1. Brown Seaweed
8.2.2. Green Seaweed
8.2.3. Red Seaweed
8.3. Marine Bacteria
8.3.1. Actinobacteria
8.3.2. Proteobacteria
8.4. Marine Fungi
8.5. Marine Sponges
8.5.1. Halichondria Okadai
8.5.2. Theonella Zwinhoei
8.6. Microalgae
8.6.1. Chlorella
8.6.2. Dunaliella
8.6.3. Spirulina
9. Marine Derived Drugs Market, by Drug Type
9.1. Introduction
9.2. Anti-Inflammatory Agents
9.3. Antibiotics
9.3.1. Broad-Spectrum Antibiotics
9.3.2. Narrow-Spectrum Antibiotics
9.4. Anticancer Agents
9.4.1. Apoptotic Agents
9.4.2. Cytotoxic Drugs
9.5. Antimicrobial
9.6. Antiviral Agents
9.6.1. Influenza Treatment
9.6.2. Retroviral Treatment
9.7. Cardiovascular Drugs
9.7.1. Anticoagulants
9.7.2. Blood Pressure Regulators
10. Marine Derived Drugs Market, by Form
10.1. Introduction
10.2. Liquid
10.3. Semi Solid
10.4. Solid
11. Marine Derived Drugs Market, by Applications
11.1. Introduction
11.2. Cosmeceuticals
11.2.1. Hair Care
11.2.2. Skin Care
11.3. Nutraceuticals
11.3.1. Dietary Supplements
11.3.2. Functional Foods
11.4. Pharmaceuticals
11.4.1. Cardiovascular
11.4.2. Oncology
12. Marine Derived Drugs Market, by End-User
12.1. Introduction
12.2. Hospitals & Clinics
12.3. Research & Academic Institutions
13. Americas Marine Derived Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Marine Derived Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Marine Derived Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Archimica S.p.A
16.3.2. Asahi Kasei Finechem Co., Ltd.
16.3.3. BASF Pharma (Callanish) Limited
16.3.4. Biesterfeld SE
16.3.5. BioMarin Pharmaceutical Inc.
16.3.6. Bristol-Myers Squibb Company
16.3.7. DSM-Firmenich AG
16.3.8. Eli Lilly and Company
16.3.9. F. Hoffmann-La Roche Ltd
16.3.10. LGM Pharma
16.3.11. Mac-Chem Products (India) Pvt.Ltd
16.3.12. MARINE LIFESCIENCES
16.3.13. Marinomed Biotech AG
16.3.14. Pfizer Inc.
16.3.15. Pharmamar S.A.
16.3.16. Takeda Pharmaceutical Company Limited.
16.3.17. Zhejiang Hisun Pharmaceutical Co. Ltdv
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MARINE DERIVED DRUGS MARKET: RESEARCHAI
FIGURE 26. MARINE DERIVED DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. MARINE DERIVED DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. MARINE DERIVED DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROWN SEAWEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROWN SEAWEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY GREEN SEAWEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY GREEN SEAWEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RED SEAWEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RED SEAWEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ACTINOBACTERIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ACTINOBACTERIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PROTEOBACTERIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PROTEOBACTERIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE FUNGI, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE FUNGI, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HALICHONDRIA OKADAI, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HALICHONDRIA OKADAI, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY THEONELLA ZWINHOEI, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY THEONELLA ZWINHOEI, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CHLORELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CHLORELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DUNALIELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DUNALIELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SPIRULINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SPIRULINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APOPTOTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APOPTOTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CYTOTOXIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CYTOTOXIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY INFLUENZA TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY INFLUENZA TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RETROVIRAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RETROVIRAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BLOOD PRESSURE REGULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY BLOOD PRESSURE REGULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HAIR CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SKIN CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 196. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 197. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 198. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 199. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 200. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 201. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 202. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 203. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 204. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 205. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 206. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 207. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 208. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 209. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 210. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 211. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 212. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 213. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 214. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 215. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 216. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 217. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 218. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 219. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 220. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 221. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 222. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 223. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 224. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 225. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 232. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 233. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 236. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER AGENTS, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY ANTIVIRAL AGENTS, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY CARDIOVASCULAR DRUGS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY COSMECEUTICALS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY NUTRACEUTICALS, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MACROALGAE, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE BACTERIA, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MARINE SPONGES, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MICROALGAE, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MA

Samples

Loading
LOADING...

Companies Mentioned

  • Archimica S.p.A
  • Asahi Kasei Finechem Co., Ltd.
  • BASF Pharma (Callanish) Limited
  • Biesterfeld SE
  • BioMarin Pharmaceutical Inc.
  • Bristol-Myers Squibb Company
  • DSM-Firmenich AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • LGM Pharma
  • Mac-Chem Products (India) Pvt.Ltd
  • MARINE LIFESCIENCES
  • Marinomed Biotech AG
  • Pfizer Inc.
  • Pharmamar S.A.
  • Takeda Pharmaceutical Company Limited.
  • Zhejiang Hisun Pharmaceutical Co. Ltdv

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.48 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Marine Derived Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Marine Derived Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Wound Care Biologics - Global Strategic Business Report - Product Image

Wound Care Biologics - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market by Product Type, Therapy Type, Transplant Type, Patient Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Organ Transplant Immunosuppressant Drugs Market by Product Type, Therapy Type, Transplant Type, Patient Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Biopharmaceutical Excipients Market by Product (Binders, Coatings, Diluents), Source (Natural Excipients, Synthetic Excipients), Formulation Type, End User - Global Forecast 2025-2030 - Product Image

Biopharmaceutical Excipients Market by Product (Binders, Coatings, Diluents), Source (Natural Excipients, Synthetic Excipients), Formulation Type, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Microbial API - Global Strategic Business Report - Product Image

Microbial API - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From

About the Marine Derived Drug Market

The Marine Derived Drug market is a subset of the biopharmaceutical industry, which focuses on the development and commercialization of drugs derived from marine organisms. These drugs are typically derived from marine organisms such as bacteria, fungi, algae, and invertebrates, and are used to treat a variety of diseases and conditions. Marine derived drugs are often used to treat cancer, infectious diseases, and neurological disorders. The Marine Derived Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.